| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $169K | +52.3% |
| Cost of Revenue | $37K | +42.5% |
| Gross Profit | $132K | +55.3% |
| R&D Expense | $1.2M | -38.0% |
| SG&A Expense | $4.2M | +10.7% |
| Operating Income | -$7.8M | -36.1% |
| Interest Expense | -$3K | -108.2% |
| Pre-tax Income | -$7.6M | -63.7% |
| Net Income | -$7.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $574K | -1.0% |
| Short-term Investments | $2.9M | +22.7% |
| Accounts Receivable | $13K | +39.2% |
| Inventory | $175K | +11.6% |
| Current Assets | $4.0M | +15.5% |
| Total Assets | $4.2M | +16.3% |
| Current Liabilities | $547K | +28.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -2.8% |
| Investing Cash Flow | -$578K | -113.0% |
| Financing Cash Flow | $4.5M | +2358.1% |
| -63.6% |
| EPS (Basic) | -$0.83 | -31.7% |
| EPS (Diluted) | -$0.83 | -31.7% |
| Total Liabilities |
| $547K |
| +28.5% |
| Stockholders' Equity | $3.7M | +14.6% |